Adherence to Early Antiretroviral Therapy: Results From HPTN 052, a Phase III, Multinational Randomized Trial of ART to Prevent HIV-1 Sexual Transmission in Serodiscordant Couples
David D. Celentano(Johns Hopkins University), Theresa Gamble(University of Utah), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Kenneth H. Mayer(Miriam Hospital), Steven A. Safren(University of Miami), San‐San Ou, Marybeth McCauley(Family Health International 360), Ying Qing Chen(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Irving Hoffman(Communities In Schools of Orange County), Mina C. Hosseinipour, Nagalingeswaran Kumarasamy(YR Gaitonde Centre for AIDS Research and Education), Myron S. Cohen(University of North Carolina at Chapel Hill)
Cited by 4
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891